SDH is a protein that is based in the mitochondria. Its loss causes a major energy and metabolic crisis. Despite this, some types of cells can 'benefit' from the loss of SDH and continue to [...]
Our Global Consultant, Piga Fernández, Executive Director of Fundación GIST Chile has asked us to help support the passage of the National Cancer Law in Chile. In 2020, cancer will be the number one cause of death [...]
How First Descents Helps Young Adults Impacted by Cancer By Liz Skree, LRG Contributor and GIST Survivor Photo credit First Descents A cancer diagnosis at any age is life-changing, daunting, and difficult. [...]
How to Make 2/3 = 1 (100%) In a recent discussion about the frequency of mutations in GIST, we noted that the most common mutation is KIT exon 11, which makes up about 2/3 [...]
Our Commitment to the Biden Cancer Initiative We are excited to launch an innovative initiative to strengthen and advance research for effective treatments of a rare subset of Gastrointestinal Stromal Tumor (GIST) patients, who [...]
On September 21st, 2018, Vice President Joe Biden and Dr. Jill Biden convened a national Biden Cancer Summit, with the anchor event in Washington D.C., and more than 450 Community Summits held where people [...]
A tribute by Michael Josephy, LRG Contributor My dear wife, Elsie María Hernández Saborío, passed away August 7th after a long battle with GIST. I miss her greatly. Elsie was born and raised in [...]
The Clinical Trials Transformation Initiative (CTTI) Steering Committee gathered in Washington, D.C. on September 25th to discuss how clinical trials fit within scientific strategies to address public health priorities, review the portfolio of initiatives, [...]
Ron & Kim Agypt The Life Raft Group welcomed Ron Agypt to the Board this month. Ron is a retired insurance executive, father of three, and grandfather of five. Ron and his [...]
If you haven't visited our website lately, it's likely you haven't seen some of our new features. We'll be featuring a unique feature in each newsletter. This issue the spotlight is on the Patient [...]
